Evidence map›Paper›PMID 28194841›Full record

Trial reportEuropean journal of heart failure2017

Impaired left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: insights from the RELAX trial.

Adam D DeVore, Steven McNulty, Fawaz Alenezi, Mads Ersboll, Justin M Vader, Jae K Oh, Grace Lin, Margaret M Redfield, Gregory Lewis, Marc J Semigran and 3 more

Abstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in European journal of heart failure, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 92 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
92citing papers in PubMed, 1 pooled it
10.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

92 citing papers in PubMed, 1 synthesis or guideline pooled it, 180 citations in OpenAlex.

  1. Highlights in heart failure.ESC heart failure · 2019
    Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Clinical and prognostic impact of left atrial strain in non-ischemic cardiomyopathies.The international journal of cardiovascular imaging · 2026
    Review
  12. Review
  13. Article
  14. Low-flow in aortic valve stenosis patients with reduced ejection fraction does not depend on left ventricular function.Clinical research in cardiology : official journal of the German Cardiac Society · 2025
    Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

32 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 2 countries.

Adam D DeVoreDuke Clinical Research Institute, Durham, NC, USA.
Steven McNultyDuke Clinical Research Institute, Durham, NC, USA.
Fawaz AleneziDepartment of Medicine, Duke University School of Medicine, 2400 Pratt Street, NP-8064, Durham, NC, 27705, USA.
Mads ErsbollDepartment of Cardiology, The Heart Centre, University Hospital Rigshospitalet, Copenhagen, Denmark.
Justin M VaderDepartment of Medicine, Division of Cardiology, Washington University School of Medicine, St. Louis, MO, USA.
Jae K OhDivision of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA.
Grace LinDivision of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA.
Margaret M RedfieldDivision of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA.
Gregory LewisDepartment of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Marc J SemigranDepartment of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Kevin J AnstromDuke Clinical Research Institute, Durham, NC, USA.
Adrian F HernandezDuke Clinical Research Institute, Durham, NC, USA.
Eric J VelazquezDuke Clinical Research Institute, Durham, NC, USA.
Clinical Research Institute · USDuke University · USMassachusetts General Hospital · USMayo Clinic · USMayo Clinic in Arizona · USRigshospitalet · DKWashington University in St. Louis · US

Funding

Heart Failure Clinical Research Network Coordinating CenterU10HL084904 · NHLBI · DUKE UNIVERSITY · PI ANSTROM, KEVIN J, HERNANDEZ, ADRIAN · 2012 to 2018
$38.0M
NHLBI NIH HHS U10 HL084904
6 · The paper itself

Abstract

backgroundWhile abnormal left ventricular (LV) global longitudinal strain (GLS) has been described in patients with heart failure with preserved ejection fraction (HFpEF), its prevalence and clinical significance are poorly understood. METHODS AND

resultsPatients enrolled in the RELAX trial of sildenafil in HFpEF (LV ejection fraction ≥50%) in whom two-dimensional, speckle-tracking LV GLS was possible (n = 187) were analysed. The distribution of LV GLS and its associations with clinical characteristics, LV structure and function, biomarkers, exercise capacity and quality of life were assessed. Baseline median LV GLS was -14.6% (25th and 75th percentile, -17.0% and -11.9%, respectively) and abnormal (≥ - 16%) in 122/187 (65%) patients. Patients in the tertile with the best LV GLS had lower N-terminal pro-brain natriuretic peptide (NT-proBNP) [median 505 pg/mL (161, 1065) vs. 875 pg/mL (488, 1802), P = 0.008) and lower collagen III N-terminal propeptide (PIIINP) levels [median 6.7 µg/L (5.1, 8.1) vs. 8.1 µg/L (6.5, 10.5), P = 0.001] compared with the tertile with the worst LV GLS. There was also a modest linear relationship with LV GLS and log-transformed NT-proBNP and PIIINP (r = 0.29, P < 0.001 and r = 0.19, P = 0.009, respectively). We observed no linear association of LV GLS with Minnesota Living with Heart Failure scores, 6-min walk distance, peak oxygen consumption, or expiratory minute ventilation/carbon dioxide excretion slope.

conclusionsImpaired LV GLS is common among HFpEF patients, indicating the presence of covert systolic dysfunction despite normal LV ejection fraction. Impaired LV GLS was associated with biomarkers of wall stress and collagen synthesis and diastolic dysfunction but not with quality of life or exercise capacity, suggesting other processes may be more responsible for these aspects of the HFpEF syndrome.

Indexed as

AgedAged, 80 and overBiomarkersDouble-Blind MethodEchocardiographyExercise ToleranceFemaleFollow-Up StudiesHeart Failure, SystolicHeart VentriclesHumansMaleMiddle AgedMyocardial ContractionNatriuretic Peptide, BrainOxygen ConsumptionBiomarkersNatriuretic Peptide, BrainPeptide Fragmentspro-brain natriuretic peptide (1-76)Procollagenprocollagen Type III-N-terminal peptideEchocardiographyHeart failureStrain

Identifiers

PMID28194841
PMCPMC5511088
OpenAlexW2588847604

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.